Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
about
The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidenceThe 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its UseTreatment of diabetic sensory polyneuropathy.Pharmacological Approaches for the Management of Persistent Pain in Older Adults: What Nurses Need to KnowTreatment of neuropathic pain with 5% lidocaine-medicated plaster: Five years of clinical experience.Duloxetine in the management of chronic musculoskeletal painLidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study.A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritisHealth economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia.Pain associated with diabetic peripheral neuropathy: a review of available treatmentsOpioid therapy for osteoarthritis and chronic low back pain.Pharmacological treatment of diabetic neuropathic pain.Clinical Approach to the Treatment of Painful Diabetic Neuropathy.Management of chronic noncancer pain in depressed patients.Update on neuropathic pain treatment: ion channel blockers and gabapentinoids.Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases.The Efficacy of Systemic Lidocaine in the Management of Chronic Pain: A Literature Review.Investigation of drug delivery by iontophoresis in a surgical wound utilizing microdialysis.Pain Part 5a: Chronic (Neuropathic) Orofacial Pain.Classification of patients with pain based on neuropathic pain symptoms: comparison of an artificial neural network against an established scoring system.
P2860
Q26765263-A7AE52AD-BB57-4C4E-8C73-F1378E1D0463Q28069535-240388B0-3F3D-432A-A03C-5FE325875616Q33393882-92EAF338-1DE2-42D5-B6D3-078B364F26CDQ33803025-F46292ED-D299-4614-A860-A19B0176565BQ35453240-99A741C9-8A06-481C-B8DE-543392F3F05CQ36071024-9843D195-0E0B-4E01-BC0F-49DCE9DDBBCAQ36329277-E9B95EAF-6A67-46B2-AAA1-52DE107CE43FQ36975234-058EA04D-6634-4EF9-8CA0-C5A01C1D4932Q37359019-5C46BC63-ADD3-4DF9-A952-DEDC12087335Q37596278-6067DA86-3414-44B4-9C78-81818911EC54Q37810414-DD6BADC3-6AC8-4158-8EE0-91E2AE7CDEC5Q37858519-591A2886-81E4-40DC-AEF1-6559A1C89278Q37895130-FB93E910-94FA-41E2-AB02-6D7521808635Q37929505-88039C93-C6F8-4622-BAE5-0A762EB7B15DQ38124283-CA75D026-F4CC-4A3E-BEEC-B5C96179EC52Q38798588-ED04FD01-95D6-4628-B6FF-7BF9FA5D2A6AQ39322000-36124ABE-3E19-4691-B42D-2E57572D18C8Q41450025-1B57670C-F350-40C8-981E-0F84F7CEDF66Q43249580-5CE470D1-E107-4974-A427-C835FD4E57C3Q47613508-F02B3F82-CAF8-4B80-8817-923192D73E72Q51943458-B7235F69-87CB-4DEF-8A3B-BEF9B81F9DEA
P2860
Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Effectiveness of the lidocaine ...... th the Neuropathic Pain Scale.
@en
Effectiveness of the lidocaine ...... th the Neuropathic Pain Scale.
@nl
type
label
Effectiveness of the lidocaine ...... th the Neuropathic Pain Scale.
@en
Effectiveness of the lidocaine ...... th the Neuropathic Pain Scale.
@nl
prefLabel
Effectiveness of the lidocaine ...... th the Neuropathic Pain Scale.
@en
Effectiveness of the lidocaine ...... th the Neuropathic Pain Scale.
@nl
P2093
P921
P356
P1476
Effectiveness of the lidocaine ...... th the Neuropathic Pain Scale.
@en
P2093
Arnold R Gammaitoni
Bradley S Galer
Charles E Argoff
Mark P Jensen
Napoleon Oleka
P356
10.1185/030079904X12960
P407
P478
20 Suppl 2
P577
2004-01-01T00:00:00Z